Navigation Links
New FDA program adds to tools to curb opiod abuse in United States
Date:8/1/2012

PHILADELPHIA -- A new risk management plan from the U.S. Food and Drug Administration to help clinicians properly prescribe drugs with addiction potential aims to help reduce the growing epidemic of opioid abuse in the United States. With deaths associated with these drugs, often sold illegally, now reaching toward 14,000 each year including the fatal shootings of two Philadelphia teenagers last week in a house where police found large quantities of Percocet and morphine, prescription drug pads, and more than $100,000 in cash -- the authors of a Viewpoint piece in the new issue of the Journal of the American Medical Association say the new plan represents a promising opportunity to cut the amount of addictive prescription drugs in circulation for sale and abuse.

The authors, medical toxicologists Jeanmarie Perrone, MD, an associate professor of Emergency Medicine in the Perelman School of Medicine at the University of Pennsylvania, and Lewis S. Nelson, MD, a professor of Emergency Medicine at the New York University School of Medicine, highlight the FDA's new Risk Evaluation and Mitigation Strategy (REMS), which seeks to manage and prevent the serious risks of misuse and addiction associated with long-acting and extended-release opioids such as OxyContin.

The plan, adopted in early July, includes requirements for prescriber continuing education and patient counseling. A separate REMS for fentanyl lozenges and nasal sprays has also been implemented, requiring a patient-prescriber agreement outlining the expectations and responsibilities for using the drugs safely.

In addition to rolling out the new REMS in a way that's easy and quick for prescribers to use, the authors support a closer look at evidence associated with the true efficacy and risks associated with using opioids for chronic noncancer pain, which has been a large driver of increased prescriptions for these medications over the past 20 years. They also call for a revision of drug labeling to reflect the latest science about risk-benefit information and the most appropriate uses of the medications, a move that was also urged in a petition to the FDA signed by physicians and public health activists last week. The authors also suggest the creation of a REMS for short-acting opioids, which studies have shown is widely associated with nonmedical use.

"There is no single magic bullet for addressing opioid abuse in the community, which has become an enormous public health problem. But we are optimistic that this is the first of several steps needed to enhance safe prescribing of these powerful drugs," Perrone says.

Dr. Perrone is available to discuss opioid abuse and misuse, proper prescribing methods and indications for use of these drugs, and efforts to curtail the epidemic of opioid abuse and deaths, such as REMS and state-run prescription drug monitoring programs.


'/>"/>
Contact: Holly Auer
holly.auer@uphs.upenn.edu
215-349-5659
University of Pennsylvania School of Medicine
Source:Eurekalert

Related medicine news :

1. Screening programs detect cases of undiagnosed rheumatic heart disease in low-resource countries
2. Ivy Neurological Sciences Internship program funded at TGen
3. Brief training program improves resident physicians empathy with patients
4. Southeast program to fight diabetes awarded nearly $10 million by HHS
5. Program to coordinate regional systems to speed heart attack care
6. Fewer prostate cancer surgery complications found in teaching hospitals with fellowship programs
7. UC San Diego Superfund Research Program receives $15 million grant renewal
8. UCLA launches first face transplantation program in western US
9. Rutgers leads effort to replicate care management programs in 4 U.S. cities
10. Steffi Nossen School of Dance Gears Up for Summer with Exciting Programming for All Ages
11. Coronary rehabilitation programs in Europe are underused
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... York, NY & Greenwich, CT (PRWEB) , ... March 01, 2017 ... ... many runners, especially in the winter months when people don’t want to stop training ... the knees – and setting the treadmill to a small incline can help protect ...
(Date:3/1/2017)... ... , ... “McFarnia”: a suspenseful tale of a father who vanishes without a ... disappearance. “McFarnia” is the creation of published author Tony Pierzchala, a former Army man, ... a Chaplain with Transport for Christ at a truck stop in the Greensboro area. ...
(Date:3/1/2017)... ... ... of Love”: a tale of young love and war. ““Letter of Love”” is the ... Salvador, wife, mother, and co-founder of a Christian College. , “I turned to ... poor communities, and I study psychology. I lived the civil war. ” --Maria Teresa ...
(Date:3/1/2017)... ... , ... “The Affair is Over Now Go Live Your Life Abundantly”: a ... affair. “The Affair is Over Now Go Live Your Life Abundantly” is the creation ... dedicated her professional life to teaching and writing about marriage and family life in ...
(Date:2/28/2017)... ... , ... Answering strong demand for its medical device software design and development ... in the Soma neighborhood in San Francisco on March 1, 2017. The opening also ... systems architecture subject matter experts. , Orthogonal serves a sizeable clientele in the Bay ...
Breaking Medicine News(10 mins):
(Date:3/1/2017)... DIEGO , March 1, 2017  Aethlon ... European Patent Office has granted European Patent Number ... In recent years, exosomes have emerged ... a wide range of disease conditions, including cancer, ... (CTE).  This granted European Patent is an important ...
(Date:3/1/2017)... 1, 2017  Numotion, the nation,s leading provider of ... Tek RMD ("robotic mobilization device") by Matia Robotics in ... is a motorized standing movement device that offers the ... to complete everyday activities from a standing position. Unlike ... RMD unassisted. Numotion is the exclusive distributor of the ...
(Date:3/1/2017)... ... and Markets has announced the addition of the "Global Infertility ... The Global Infertility Therapy Partnering Terms and Agreements since 2010 ... into by the world,s leading healthcare companies. The report ... discovery or development stage whereby the licensee obtains a right or ...
Breaking Medicine Technology: